Sinopharm reports no change in issued share capital for September

Sinopharm Group Co. Ltd.'s monthly return for September 2025 indicated no movements in its issued share capital for the period. The company's H shares maintained an issued share capital of 1,341,810,740 shares. Similarly, its unlisted Domestic Shares remained at 1,778,845,451 shares.

The total authorised/registered share capital for Sinopharm at the end of September 2025 stood at RMB 3,120,656,191. This figure is derived from 1,341,810,740 H shares at a par value of RMB 1 each and 1,778,845,451 Domestic Shares, also with a par value of RMB 1 each.

The company, incorporated in the People's Republic of China, noted that the concept of "authorised share capital" is not applicable in its jurisdiction. No share options, warrants, convertibles, or other agreements to issue shares were reported for the month.